| Cyclosporine and other immunosuppressive agents: current and future role in the treatment of inflammatory bowel disease. | |
| | |
MedLine Citation:
|
PMID: 8480721 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
|
Authors:
|
D H Present |
Publication Detail:
|
Type: Comment; Editorial |
Journal Detail:
|
Title: The American journal of gastroenterology Volume: 88 ISSN: 0002-9270 ISO Abbreviation: Am. J. Gastroenterol. Publication Date: 1993 May |
Date Detail:
|
Created Date: 1993-05-27 Completed Date: 1993-05-27 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0421030 Medline TA: Am J Gastroenterol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 627-30 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
6-Mercaptopurine
/
therapeutic use Azathioprine / therapeutic use Colitis, Ulcerative / drug therapy* Crohn Disease / drug therapy* Cyclosporine / adverse effects, therapeutic use* Humans Immunosuppressive Agents / adverse effects, therapeutic use* Intestinal Neoplasms / chemically induced, epidemiology Lymphoma / chemically induced, epidemiology Risk Factors |
| Chemical | |
Reg. No./Substance:
|
0/Immunosuppressive Agents; 446-86-6/Azathioprine; 50-44-2/6-Mercaptopurine; 59865-13-3/Cyclosporine |
| Comments/Corrections | |
Comment On:
|
Am J Gastroenterol. 1993 May;88(5):640-5
[PMID:
8480724
]
Am J Gastroenterol. 1993 May;88(5):646-9 [PMID: 8480725 ] |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Three-stage activator treatment of a severe skeletal Class II, open bite malocclusion.
Next Document: Current treatment modalities for symptomatic gallstones.